Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Anticancer Res. 2013 May;33(5):2029-35.
The majority of alveolar rhabdomyosarcoma (ARMS) are distinguished through the paired box 3-forkhead box protein O1 (PAX3-FOXO1) fusion oncoprotein, being generated by a 2;13 chromosomal translocation. This fusion-positive ARMS is the most clinically difficult type of rhabdomyosarcoma. The present study characterized four genes [gremlin 1 (GREM1), death-associated protein kinase-1 (DAPK1), myogenic differentiation-1 (MYOD1), and hairy/enhancer-of-split related with YRPW motif-1 (HEY1)] as targets of PAX3-FOXO1.
The expression of the four genes, PAX3-FOXO1, and v-myc myelocytomatosis viral-related oncogene, neuroblastoma-derived (avian) (MYCN) was determined in various ARMS cell models and primary tumors. The roles of PAX3-FOXO1 and MYCN expression were examined.
Pulse-chase and cycloheximide experiments suggest that GREM1, DAPK1, and MYOD1 are directly regulated by PAX3-FOXO1. PAX3-FOXO1 appears to indirectly down-regulate HEY1 by up-regulating MYCN. Data reveal that the growth-suppressive activity of high PAX3-FOXO1 expression is closely-associated with up-regulation of the GREM1 and DAPK1 tumor-suppressor genes.
This study characterized four downstream targets of PAX3-FOXO1 that contribute to the biological activities of growth suppression and myogenic differentiation.
大多数肺泡横纹肌肉瘤(ARMS)通过配对盒 3-叉头框蛋白 O1(PAX3-FOXO1)融合癌蛋白来区分,该融合癌蛋白由 2;13 号染色体易位产生。这种融合阳性 ARMS 是横纹肌肉瘤中最具临床挑战性的类型。本研究确定了四个基因 [gremlin 1(GREM1)、凋亡相关蛋白激酶-1(DAPK1)、肌生成分化-1(MYOD1)和含 YRPW 基序的头发/增强子分裂相关蛋白-1(HEY1)] 为 PAX3-FOXO1 的靶标。
在各种 ARMS 细胞模型和原发性肿瘤中测定了四个基因、PAX3-FOXO1 和 v-myc 髓母细胞瘤病毒相关癌基因,神经母细胞瘤衍生(禽)(MYCN)的表达。检查了 PAX3-FOXO1 和 MYCN 表达的作用。
脉冲追踪和环己酰亚胺实验表明,GREM1、DAPK1 和 MYOD1 被 PAX3-FOXO1 直接调控。PAX3-FOXO1 似乎通过上调 MYCN 间接下调 HEY1。数据表明,高 PAX3-FOXO1 表达的生长抑制活性与 GREM1 和 DAPK1 肿瘤抑制基因的上调密切相关。
本研究确定了 PAX3-FOXO1 的四个下游靶标,这些靶标有助于生长抑制和肌生成分化的生物学活性。